Trust Point’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Trust Point's LLY Position: Q3 2026 in Review
Trust Point increased its Eli Lilly (LLY) stake by 17% in Q3 2026, buying an estimated $616K and bringing the position to 3,518 shares worth $4.07M. The position accounts for 0.3% of the portfolio, ranked #42.
Trust Point first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Trust Point held 3,518 shares of Eli Lilly worth $4.07M as of Q3 2026.
- Trust Point bought 522 Eli Lilly shares in Q3 2026, an estimated $616K.
- Eli Lilly made up 0.3% of Trust Point's portfolio in Q3 2026, its #42 holding.
- Trust Point first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.